Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting

Kardiologiya

Volumn 49, Issue 2, 2009, Pages 15-21

  Lopatin, Yu M ^a,b   Dronova, E P ^a,b  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Volgograd Regional Cardiology Centre   (Russian Federation)

Author keywords

Coronary artery bypass grafting; Ischemic heart disease; Trimetazidine MR

Indexed keywords

TRIMETAZIDINE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DELAYED RELEASE FORMULATION; DOSE RESPONSE; ECONOMICS; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TREATMENT OUTCOME;

ADULT; AGED; CORONARY ARTERY BYPASS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 66549110321     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kanlor P., Lucien A., Kozak R., Lopaschuk G The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glu-cose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86:580-588. (Pubitemid 30165050)
2. Lagadic-Gossman D., Le Prigent K., Feuvray D. Effects of trimetaz-idine on pH regulation in the rat isolited ventricular myocyte. Br J Pharmacol 1996; 117:831-838.
3. Guarnieri C, Fimell C, Muscari C. Effects of trimetazidine on the cal-cium transport and oxidative phosphorylation of isolated rat heart mitochondria. Basic Res Cardiol 1997; 92:90-95. (Pubitemid 27198772)
4. Maupoil V., Rochette L., Tabard A. et al. Direct measurement of free radical generation in isolated rat heart by electron paramagnetic resonance spec-troscopy: effect of trimetazidine. Adv Exp Md Biol 1990; 264:373-376. (Pubitemid 20316344)
5. Drake-Holland A.J., Belcher P.R., Hynd J., Noble M.I. Infarct size in rabbits: a modified method illustrated by effects of propranolol and trimetaz-idine. Basic Res Cardiol 1993; 88:250-258. (Pubitemid 23249264)
6. Williams F.M., Tanda K, Kus M., Williams T.J. Trimetazidine inhib-its neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits. J Cardiovasc Pharmacol 1993; 22:828-833. (Pubitemid 23360404)
7. Kober G., Pennaforte S., Buck T. et al. Myocardial cytoprotection during per-cutaneous transluminal coronary angioplasty. Eur Heart J 1993; 14 (SUPPL. G). 6-11. (Pubitemid 24040068)
8. Birand A., Kudaiberdieva G.Z., Batyraiiev TA et al. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty. Angiology 1997; 48:413-422. (Pubitemid 27255014)
9. Steg P.G., Grollier G, Gallay P. et al. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. Int J Cardiol 2001; 77: 263-273. (Pubitemid 32155912)
10. Polonski L., Dec I., Wojnar R., Wilczek K. Trimetazidine limits the ef-fects of myocardial ischaemia during percutaneous coronary angioplasty. Curr Med Res Opin 2002; 18:389-396. (Pubitemid 35448535)
11. Labrou A., Giannoglou G, Ziolas D. et al. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. Am J Cardiovasc Drugs 2007; 7:143-150. (Pubitemid 46790270)
12. Tunerir B., Colak O., Alatas O. et al. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting. Ann Thorac Surg 1999; 68:2173-2176. (Pubitemid 30027844)
13. Vedrinne J.M., Vedrinne C, Bompard D. et al. Myocardial protection during coronary artery bypass graft surgery: a randomized, doubleblind, pla-cebo-controlled study with trimetazidine. Anesth Analg 1996; 82:712-718. (Pubitemid 26111564)
14. Fabiani J.N., Ponzio O., Emerit I. et al. Cardioprotective effect of trimetazidine during coronary artery graft surgery. J Cardiovasc Surg (Torino) 1992; 33:486-491.
15. Ruzyllo W., Szwed H., Sadowski Z. et al. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study. Curr Med Res Opin 2004; 20:1447-1454. (Pubitemid 39361348)
16. Belardinelli R., Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Eur Heart J 2001; 22:2164-2170. (Pubitemid 33139462)
17. Di Napoli P., Taccardi A.A, Barsotti A. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in pa-tients with ischaemic dilated cardiomyopathy. Heart 2005; 91:161-165.